oncology

SystImmune & Biokin Secure First China Approval for Revolutionary Bispecific ADC Iza-bren

by

China Approves First Bispecific ADC for Nasopharyngeal Cancer: What It Means for Patients and Drug Development China’s National Medical Products Administration (NMPA) has approved Iza-bren (BL-B01D1), a first-in-class bispecific antibody-drug conjugate (ADC), for treating recurrent or metastatic nasopharyngeal carcinoma (NPC) after failure of platinum chemotherapy and PD-1/PD-L1 inhibitor therapy. Developed by SystImmune and its parent … Read more

New Spatial Map Uncovers Bladder Cancer Treatment Vulnerabilities

by

Researchers at The University of Texas MD Anderson Cancer Center have mapped the spatial architecture of muscle-invasive bladder cancer, identifying how tumor cell states and immune environments interact within specific regions of a tumor. Published in Cancer Discovery, the study reveals that bladder cancer is not a uniform disease, but a complex landscape where luminal … Read more

New CT Scan Biomarker Predicts Gastric Cancer Outcomes

by

Researchers at the State University of Campinas (UNICAMP) in Brazil have identified a new biomarker, the Visceral-Muscular Density (VMD) index, that significantly improves prognosis prediction for gastric cancer patients. By analyzing radiodensity patterns in CT scans—a standard diagnostic tool—the team discovered that VMD can distinguish between high-risk and low-risk disease progression, potentially allowing for more … Read more

Fibroblast Signaling and Angiogenesis in NSCLC: Key Mechanisms

by

Researchers at the University of Barcelona have identified that tumor-associated fibroblasts (TAFs) act as primary regulators of blood vessel formation in non-small cell lung cancer (NSCLC), explaining why lung adenocarcinoma (LUAD) and squamous cell carcinoma (LUSC) respond differently to anti-angiogenic therapies. Published in Cell Death & Disease, the study shows that fibroblast-driven differences in oxygen … Read more

How Targeted Reminders Boost Serious Illness Conversations in Cancer Care

by

Targeted “nudges” sent to oncology patients and their clinicians significantly increase the frequency of critical end-of-life care conversations, according to a randomized controlled trial published in the JNCCN—Journal of the National Comprehensive Cancer Network. By combining patient questionnaires with clinician email reminders, researchers at the Dana-Farber Cancer Institute found that patients had 79% higher odds … Read more

Classifying Breast Cancer Subtypes Using Raman Spectroscopy and Machine Learning

by

Raman spectroscopy (RS) can identify cancerous breast tissue with 97.84% sensitivity and 97.18% specificity, according to a study published in Nature Scientific Reports. By analyzing the molecular signatures of tissue samples, the technology distinguishes between healthy tissue and three distinct cancer subtypes—invasive ductal carcinoma, invasive lobular carcinoma, and ductal carcinoma in situ—offering a potential path … Read more

Weight Loss Drugs May Prevent Obesity-Related Cancers

by

Research published in the journal Annals of Oncology indicates that GLP-1 receptor agonists (GLP-1 RAs) are associated with a 41% reduction in overall cancer risk among obese, non-diabetic adults. This study of more than 229,000 patients suggests these medications may offer significant benefits for cancer prevention beyond simple weight management. Which cancers are linked to … Read more

Cancer Survivors Face Employment and Social Hurdles Post-Recovery

by

Beyond the Diagnosis: The New Frontier of Survivorship For millions, the final round of chemotherapy is hailed as a victory. But as medical advancements continue to increase survival rates, a new, complex reality is emerging: the “second diagnosis.” This isn’t a medical recurrence, but a social and economic one—the struggle to reintegrate into a workforce … Read more

How Vaping Devices and Flavors Impact Your Genes

by

Beyond the Cloud: Why “One Size Fits All” Vaping Research Is Failing For years, the public health debate surrounding e-cigarettes has been binary: is vaping safer than smoking, or is it just as dangerous? New research suggests we’ve been asking the wrong question. It’s not just about whether you vape; it’s about how you vape. … Read more

Can GLP-1 Drugs Help Prevent Breast Cancer? New Study Findings

by

A New Frontier in Cancer Prevention: Could Weight-Loss Drugs Change the Game? For decades, the medical community has searched for pharmacological ways to lower breast cancer risk beyond traditional hormone-blocking therapies. Now, a compelling new study published in JCO Oncology Practice suggests that the next breakthrough in cancer prevention might already be sitting in our … Read more

© 2026 Newsy Today. All rights reserved.


For contact, advertising, copyright, issues email: [email protected]

For contact, advertising, copyright, issues email: [email protected]